✦ LIBER ✦
Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: Primary Results of the DISPERSE-2 Trial
✍ Scribed by Christopher P. Cannon; Steen Husted; Robert A. Harrington; Benjamin M. Scirica; Håkan Emanuelsson; Gary Peters; Robert F. Storey
- Book ID
- 119266971
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 215 KB
- Volume
- 50
- Category
- Article
- ISSN
- 1558-3597
No coin nor oath required. For personal study only.